Accelerate Diagnostics (AXDX)

P/S ratio as of November 2024 (TTM): 4.01

According to Accelerate Diagnostics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.41. At the end of 2024 the company had a P/S ratio of 2.26.

P/S ratio history for Accelerate Diagnostics from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	2.26	-52.26%
2023	4.73	-13.8%
2022	5.49	-82.22%
2021	30.9	-21.08%
2020	39.1	-60.67%
2019	99.4	-9.59%
2018	110	-68.35%
2017	348	-91.99%
2016	> 1000	-42.02%
2015	> 1000	6.58%
2014	> 1000	-33.07%
2013	> 1000	386.54%
2012	> 1000	5697.24%
2011	37.2	747.51%
2010	4.39	-66.98%
2009	13.3	-66.24%
2008	39.4	-80.46%
2007	201	46.93%
2006	137	143.95%
2005	56.2
2004	N/A	-100%
2003	50.8	286.67%
2002	13.1	-70.9%
2001	45.1

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Thermo Fisher Scientific TMO	4.88	21.73%	🇺🇸 USA
PerkinElmer PKI	4.31	7.30%	🇺🇸 USA
Becton Dickinson BDX	3.37	-15.98%	🇺🇸 USA
Bio-Rad Laboratories BIO	3.90	-2.88%	🇺🇸 USA
NanoString Technologies NSTG	0.0312	-99.22%	🇺🇸 USA
Bruker BRKR	2.72	-32.16%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Accelerate Diagnostics (AXDX)

P/S ratio as of November 2024 (TTM): 4.01